
Act Now for Your ACS Patients: Treat Aggressively, Combine and Start Early
Learn more
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.



.png)
Venous thromboembolism incidence in patients recommended for pharmacologic prophylaxis after cesarean delivery based on different risk stratification guidelines.

.webp)
Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.
This review describes the potential benefits of combination treatment and presents data supporting the use of single-pill combination (SPC) for increasing exposure to lipid-lowering treatment (LLT).